185
Views
12
CrossRef citations to date
0
Altmetric
Anticancer Chemotherapy

Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xia Yan, Zhou-Yu Ning, Peng Wang, Li-Ping Zhuang, Li-Tao Xu, Zhen-Feng Zhu, Jie Sheng, Ye-Hua Shen, Yong-Qiang Hua & Zhi-Qiang Meng. (2021) Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study. Expert Review of Gastroenterology & Hepatology 15:9, pages 1047-1056.
Read now

Articles from other publishers (11)

Raquel Fuentes, Juan José Serrano, Mercedes Rodríguez & Alfredo Carrato. 2021. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Clinical Pancreatology for Practising Gastroenterologists and Surgeons 530 537 .
Amit Dang, Surendar Chidirala, Prashanth Veeranki & B.N. Vallish. (2021) A Critical Overview of Systematic Reviews of Chemotherapy for Advanced and Locally Advanced Pancreatic Cancer using both AMSTAR2 and ROBIS as Quality Assessment Tools. Reviews on Recent Clinical Trials 16:2, pages 180-192.
Crossref
Dong Xu, Kai Zhang, Mingna Li, J. P. Neoptolemos, Junli Wu, Wentao Gao, Pengfei Wu, Baobao Cai, Jie Yin, Guodong Shi, Zipeng Lu, Kuirong Jiang & Yi Miao. (2020) Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis. World Journal of Surgery 44:4, pages 1260-1269.
Crossref
Yang-Yang Ma, Juan-Juan Shi, Ji-Bing Chen, Ke-Chen Xu & Li-Zhi Niu. (2020) Irreversible electroporation for liver metastasis from pancreatic cancer: A case report. World Journal of Clinical Cases 8:2, pages 390-397.
Crossref
Jinjin Sun, Yanxun Li, Lili Liu, Zhijia Jiang & Geng Liu. (2019) Aspirin use and pancreatic cancer risk. Medicine 98:51, pages e18033.
Crossref
Hong Zhu, Cheng Yi, Yaqin Zhao & Hongfeng Gou. (2018) Gemcitabine plus S-1 for metastatic pancreatic cancer. Medicine 97:41, pages e12836.
Crossref
Aleksandra Adamska & Marco Falasca. (2018) ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?. World Journal of Gastroenterology 24:29, pages 3222-3238.
Crossref
Aleksandra Adamska, Alice Domenichini & Marco Falasca. (2017) Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. International Journal of Molecular Sciences 18:7, pages 1338.
Crossref
Sinan Lu, Yuan Zhang, Xiaohu Zhou, Dongkai Zhou, Qifan Yang, Bingjie Ju, Xinyi Zhao, Zhenhua Hu, Haiyang Xie, Lin Zhou, Shusen Zheng & Weilin Wang. (2016) Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis. Scientific Reports 6:1.
Crossref
Masaya Munekage, Takuhiro Kohsaki, Sunao Uemura, Hiroyuki Kitagawa, Tsutomu Namikawa & Kazuhiro Hanazaki. (2016) Mucinous cystadenocarcinoma of the pancreas with anaplastic carcinoma: A case report and review of the literature. Molecular and Clinical Oncology.
Crossref
Dietmar Zechner, Florian Bürtin, Jonas Amme, Tobias Lindner, Tobias Radecke, Stefan Hadlich, Jens-Peter Kühn & Brigitte Vollmar. (2015) Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer. Cell & Bioscience 5:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.